Navigation Links
Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference
Date:1/4/2011

PRINCETON, N.J., Jan. 4, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the 29th Annual J.P. Morgan Healthcare Conference to be held January 10-13, 2011 at the Westin St. Francis Hotel, San Francisco, CA. Schaefer Price, President and Chief Executive Officer, will provide an overview of the company on Wednesday, January 12, 2011 at 9:00 AM (PT).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About PharmassetPharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis C virus (HCV). Our research and development efforts focus on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. We currently have four clinical-stage product candidates. RG7128, a cytosine nucleoside analog for chronic HCV infection, is in tw
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... 2014  Amgen (NASDAQ: AMGN ) today ... M.D., president of Gladstone Institutes and Gladstone,s Robert W. ... "We are pleased to welcome Dr. Sandy Williams ... Bradway , chairman and chief executive officer of Amgen. ... and his direct experience in our industry will both ...
(Date:10/17/2014)... , Oct. 17, 2014 Research ... "Research and Development Prospect of China Dialysis ... Based on the 2013 version, this ... policies about dialysis industry and the relevant effect ... about dialysis industry segmentations. Moreover, it analyzes Chinese ...
(Date:10/17/2014)... , Oct. 17, 2014 A victim of ... County doctor with a history of alcohol abuse, ... for Yes on Prop 46 today, highlighting how Prop 46 ... and alcohol testing. The ad pictures a ... reading "911-Report To ER."  Proposition 46 will enact the first ...
Breaking Medicine Technology:Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4
... Transgenomic, Inc. (OTC Bulletin Board: TBIO ... with the Dana-Farber Cancer Institute, Boston, MA, for the ... Transgenomic had licensed exclusive rights to COLD-PCR for Sanger ... the technology covered to include Ice COLD-PCR, a technique ...
... March 14, 2011 OrbusNeich today announced the ... Stent.  The Azule Stent combines the proven stent ... Chromium Stent, with a delivery system with enhanced ... OrbusNeich,s unique Dual Helix stent design, offering conformability ...
Cached Medicine Technology:Transgenomic Expands COLD-PCR License 2Transgenomic Expands COLD-PCR License 3Transgenomic Expands COLD-PCR License 4OrbusNeich Announces Availability of Azule™ Cobalt Chromium Stent 2
(Date:10/20/2014)... (PRWEB) October 20, 2014 Allegheny General ... procedure that enables physicians to repair a damaged mitral ... MitraClip system, developed by Abbott Vascular ... a progressive and life-threatening condition in which the heart’s ... to flow backward from the heart’s left ventricle into ...
(Date:10/20/2014)... Columbus, OH (PRWEB) October 20, 2014 ... joined Specialists in Obstetrics & Gynecology of Columbus, Inc., ... specialized women’s healthcare services to more than 100,000 patients ... care though all ages and stages of a women’s ... office locations in Westerville and Dublin. , ...
(Date:10/20/2014)... Washington, D.C. (PRWEB) October 20, 2014 Zereana ... was crowned Mrs. Maryland 2014 on a platform to think ... battle scars, and uses her position to raise awareness about ... on awareness for breast cancer. You say the color pink ... “But I know for a fact that it has not ...
(Date:10/20/2014)... Principle Business Enterprises, a family owned company for ... products. The company has recently made efforts to ... Premium Protection absorbent products. The company has redesigned ... a new look, and is currently working on innovative ... , The new website, developed with Thread Marketing Group ...
(Date:10/20/2014)... Rockynol Retirement Community broke ground ... The $11 million project will include the latest in ... with full-service restaurant style dining. , “We are excited ... Assisted Living apartments,” said Kara Hanzie, Rockynol Executive Director ... of care and this investment is proof of our ...
Breaking Medicine News(10 mins):Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2
... , TUESDAY, July 5 (HealthDay News) -- Youngsters who aren,t ... behavioral or emotional problems as a result, suggests new research. ... other developmental delays, may exhibit some mild behavioral issues or ... problems don,t persist after the youngsters, language skills catch up. ...
... 5 (HealthDay News) -- Children with a parent on long-term ... for mental health problems, new research suggests. In the ... Archives of Pediatrics and Adolescent Medicine , researchers examined ... 17, who had at least one parent on active duty ...
... 9.6% of lung cancer patients tested in the Lung ... reflecting how many patients might benefit from targeted therapies ... 14th World Conference on Lung Cancer in Amsterdam, hosted ... Cancer (IASLC). ,The Lung Cancer Mutation Consortium (LCMC), ...
... may identify lung cancers that respond best to tyrosine ... for personalized therapy, according to research presented at the ... by the International Association for the Study of Lung ... are becoming available for non-small cell lung cancer therapy, ...
... -- Cuddling and caressing are important ingredients for long-term ... at relationship and sexual satisfaction throughout committed relationships, but ... men than to the women. Also contrary ... to report being happy in their relationship, while women ...
... two to three times more likely to develop a life-threatening blood ... published on bmj.com today. The new study ... risk of developing a pulmonary embolism a common cause of ... that, although the risk is small equivalent to seven extra ...
Cached Medicine News:Health News:Tots Who Are 'Late Talkers' Typically Turn Out Fine: Study 2Health News:Tots Who Are 'Late Talkers' Typically Turn Out Fine: Study 3Health News:Parents' Military Deployment May Harm Kids' Mental Health 2Health News:ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortium 2Health News:PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumors 2Health News:Couples report gender differences in relationship, sexual satisfaction over time 2Health News:Couples report gender differences in relationship, sexual satisfaction over time 3Health News:Sitting for long periods doubles risk of blood clots in the lungs 2
ArcticTemp Upright Freezer -20C. Thick wall insulation keeps your samples colder. Reversible door with magnetic gaskets. 2 shelves and a wire basket. Heavy duty compressor with 5 year warranty....
Digital Thermostat. , Exteriorbaked enamel-on-steel. , Interiorwhite anodized aluminum. , Electronic temperature control. , Temperature -20C , Positive seal doors. , Keyed door lock. , Interi...
... portable, waterproof system for routine pH, mV ... compensated pH results can be obtained when ... a 3-in-1 electrode. • Fast and easy ... automatic buffer recognition for five buffers (pH ...
... 3 slide doors, 12 shelves.Over-sized compressor. Triple ... interior lighting. Self-Contained System No plumbing required. ... Full One Year Warranty on Parts & Labor ... Also available as a chromatography unit ...
Medicine Products: